1. Kim, W, Jin, YS, Lee, CS, Bin, SI, Lee, SY, Choi, KH. Influence of knee pain and low back pain on the quality of life in adults older than 50 years of age. PM R. 2015;7:955-961.
Google Scholar | Crossref | Medline2. Hadler, NM. Knee pain is the malady–not osteoarthritis. Ann Intern Med. 1992;116:598-599.
Google Scholar | Crossref | Medline3. Cross, M, Smith, E, Hoy, D, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73:1323-1330.
Google Scholar | Crossref | Medline | ISI4. Rosemann, T, Wensing, M, Joest, K, Backenstrass, M, Mahler, C, Szecsenyi, J. Problems and needs for improving primary care of osteoarthritis patients: the views of patients, general practitioners and practice nurses. BMC Musculoskelet Disord. 2006;7:48.
Google Scholar | Crossref | Medline | ISI5. Krustev, E, Rioux, D, McDougall, JJ. Mechanisms and mediators that drive arthritis pain. Curr Osteoporos Rep. 2015;13:216-224.
Google Scholar | Crossref | Medline6. Philpott, HT, O’Brien, M, McDougall, JJ. Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis. Pain. 2017;158:2442-2451.
Google Scholar | Crossref | Medline7. Savage, SR, Romero-Sandoval, A, Schatman, M, et al. Cannabis in pain treatment: clinical and research considerations. J Pain. 2016;17:654-668.
Google Scholar | Crossref | Medline8. MacCallum, CA, Russo, EB. Practical considerations in medical cannabis administration and dosing. Eur J Intern Med. 2018;49:12-19.
Google Scholar | Crossref | Medline9. Levinsohn, EA, Hill, KP. Clinical uses of cannabis and cannabinoids in the United States. J Neurol Sci. 2020;411:116717.
Google Scholar | Crossref | Medline10. Ware, MA, Wang, T, Shapiro, S, Collet, JP; COMPASS study team . Cannabis for the management of pain: assessment of safety study (COMPASS). J Pain. 2015;16:1233-1242.
Google Scholar | Crossref | Medline11. Lee, G, Grovey, B, Furnish, T, Wallace, M. Medical cannabis for neuropathic pain. Curr Pain Headache Rep. 2018;22:8.
Google Scholar | Crossref | Medline12. Lynch, ME, Campbell, F. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br J Clin Pharmacol. 2011;72:735-744.
Google Scholar | Crossref | Medline | ISI13. Nielsen, S, Germanos, R, Weier, M, et al. The use of cannabis and cannabinoids in treating symptoms of multiple sclerosis: a systematic review of reviews. Curr Neurol Neurosci Rep. 2018;18:8.
Google Scholar | Crossref | Medline14. Habib, G, Artul, S. Medical cannabis for the treatment of fibromyalgia. J Clin Rheumatol. 2018;24:255-258.
Google Scholar | Crossref | Medline15. Narang, S, Gibson, D, Wasan, AD, et al. Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy. J Pain. 2008;9:254-264.
Google Scholar | Crossref | Medline16. Sanders, GD, Neumann, PJ, Basu, A, et al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA. 2016;316:1093-1103.
Google Scholar | Crossref | Medline17. Berg, J, Lindgren, P, Fredrikson, S, Kobelt, G. Costs and quality of life of multiple sclerosis in Sweden. Eur J Health Econ. 2006;7(Suppl 2):S75-S85.
Google Scholar | Crossref | Medline18. Herzog, S, Shanahan, M, Grimison, P, et al. Systematic review of the costs and benefits of prescribed cannabis-based medicines for the management of chronic illness: lessons from multiple sclerosis. PharmacoEconomics. 2018;36:67-78.
Google Scholar | Crossref | Medline19. Ara, R, Brazier, J. Deriving an algorithm to convert the eight mean SF-36 dimension scores into a mean EQ-5D preference-based score from published studies (where patient level data are not available). Value Health. 2008;11:1131-1143.
Google Scholar | Crossref | Medline | ISI20. Carreno, A, Fernandez, I, Badia, X, Varela, C, Roset, M. Using HAQ-DI to estimate HUI-3 and EQ-5D utility values for patients with rheumatoid arthritis in Spain. Value Health. 2011;14:192-200.
Google Scholar | Crossref | Medline21. Collado-Mateo, D, Chen, G, Garcia-Gordillo, MA, et al. Fibromyalgia and quality of life: mapping the revised fibromyalgia impact questionnaire to the preference-based instruments. Health Qual Life Outcomes. 2017;15:114.
Google Scholar | Crossref | Medline22. Franks, P, Lubetkin, EI, Gold, MR, Tancredi, DJ, Jia, H. Mapping the SF-12 to the EuroQol EQ-5D index in a national US sample. Med Decis Making. 2004;24:247-254.
Google Scholar | SAGE Journals | ISI23. Grootendorst, P, Marshall, D, Pericak, D, Bellamy, N, Feeny, D, Torrance, GW. A model to estimate health utilities index mark 3 utility scores from WOMAC index scores in patients with osteoarthritis of the knee. J Rheumatol. 2007;34:534-542.
Google Scholar | Medline | ISI24. Spectrum Therapeutics . Accessed February 2020. https://shop.spectrumtherapeutics.com/collections/available
Google Scholar25. Bank of Canada . Inflation calculator. Accessed February 2020. https://www.bankofcanada.ca/rates/related/inflation-calculator/
Google Scholar26. Statistics Canada . StatsCannabis data availability: crowdsourced cannabis prices, third quarter 2018. Accessed February 2020. https://www150.statcan.gc.ca/n1/daily-quotidien/181004/dq181004a-eng.htm
Google Scholar27. Cameron, D, Ubels, J, Norström, F. On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review. Glob Health Action. 2018;11:1447828-1447828.
Google Scholar | Crossref | Medline28. Marseille, E, Larson, B, Kazi, DS, Kahn, JG, Rosen, S. Thresholds for the cost-effectiveness of interventions: alternative approaches. Bull World Health Organ. 2015;93:118-124.
Google Scholar | Crossref | Medline29. Neumann, PJ, Cohen, JT, Weinstein, MC. Updating cost-effectiveness–the curious resilience of the $50,000-per-QALY threshold. N Engl J Med. 2014;371:796-797.
Google Scholar | Crossref | Medline | ISI30. Bellnier, T, Brown, GW, Ortega, TR. Preliminary evaluation of the efficacy, safety, and costs associated with the treatment of chronic pain with medical cannabis. Ment. 2018;8:110-115.
Google Scholar31. Capano, A, Weaver, R, Burkman, E. Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: a prospective cohort study. Postgrad Med. 2019;132:56-61.
Google Scholar | Crossref | Medline32. Yassin, M, Oron, A, Robinson, D. Effect of adding medical cannabis to analgesic treatment in patients with low back pain related to fibromyalgia: an observational cross-over single centre study. Clin Exp Rheumatol. 2019;37(Suppl 116):13-20.
Google Scholar | Medline33. Cherian, JJ, Bhave, A, Kapadia, BH, Starr, R, McElroy, MJ, Mont, MA. Strength and functional improvement using pneumatic brace with extension assist for end-stage knee osteoarthritis: a prospective, randomized trial. J Arthroplasty. 2015;30:747-753.
Google Scholar | Crossref | Medline34. Draganich, L, Reider, B, Rimington, T, Piotrowski, G, Mallik, K, Nasson, S. The effectiveness of self-adjustable custom and off-the-shelf bracing in the treatment of varus gonarthrosis. J Bone Joint Surg Am. 2006;88:2645-2652.
Google Scholar | Crossref | Medline | ISI35. Petersen, W, Ellermann, A, Henning, J, et al. Non-operative treatment of unicompartmental osteoarthritis of the knee: a prospective randomized trial with two different braces-ankle-foot orthosis versus knee unloader brace. Arch Orthop Trauma Surg. 2019;139:155-166.
Google Scholar | Crossref | Medline36. Yamamoto, GJ, Ocampos, GP, Luzo, MCM, da Silva, CAC, de Farias, FES, de Rezende, MU. Randomized prospective study on the treatment of femoro-patellar osteoarthritis using bracing. Acta Ortop Bras. 2019;27:85-91.
Google Scholar | Crossref | Medline37. Braham, R, Dawson, B, Goodman, C. The effect of glucosamine supplementation on people experiencing regular knee pain. Br J Sports Med. 2003;37:45-49; discussion 49.
Google Scholar | Crossref | Medline | ISI38. Chopra, A, Saluja, M, Tillu, G, et al. Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial. Rheumatology (Oxford). 2013;52:1408-1417.
Google Scholar | Crossref | Medline39. Coulson, S, Butt, H, Vecchio, P, Gramotnev, H, Vitetta, L. Green-lipped mussel extract (Perna canaliculus) and glucosamine sulphate in patients with knee osteoarthritis: therapeutic efficacy and effects on gastrointestinal microbiota profiles. Inflammopharmacology. 2013;21:79-90.
Google Scholar | Crossref | Medline40. Frestedt, JL, Walsh, M, Kuskowski, MA, Zenk, JL. A natural mineral supplement provides relief from knee osteoarthritis symptoms: a randomized controlled pilot trial. Nutr J. 2008;7:9.
Google Scholar | Crossref | Medline41. Giordano, N, Fioravanti, A, Papakostas, P, Montella, A, Giorgi, G, Nuti, R. The efficacy and tolerability of glucosamine sulfate in the treatment of knee osteoarthritis: a randomized, double-blind, placebo-controlled trial. Curr Ther Res Clin Exp. 2009;70:185-196.
Google Scholar | Crossref | Medline | ISI42. McAlindon, T, Formica, M, LaValley, M, Lehmer, M, Kabbara, K. Effectiveness of glucosamine for symptoms of knee osteoarthritis: results from an internet-based randomized double-blind controlled trial. Am J Med. 2004;117:643-649.
Google Scholar | Crossref | Medline43. Mehta, K, Gala, J, Bhasale, S, et al. Comparison of glucosamine sulfate and a polyherbal supplement for the relief of osteoarthritis of the knee: a randomized controlled trial [ISRCTN25438351]. BMC Complement Altern Med. 2007;7:34.
Google Scholar | Crossref | Medline44. Peluso, R, Caso, F, Costa, L, et al. Mud-bath therapy and oral glucosamine sulfate in patients with knee osteoarthritis: a randomized, controlled, crossover study. Clin Exp Rheumatol. 2016;34:618-624.
Google Scholar | Medline45. Selvan, T, Rajiah, K, Nainar, MS, Mathew, EM. A clinical study on glucosamine sulfate versus combination of glucosamine sulfate and NSAIDs in mild to moderate knee osteoarthritis. ScientificWorldJournal. 2012;2012:902676.
Google Scholar | Crossref | Medline46. Trc, T, Bohmova, J. Efficacy and tolerance of enzymatic hydrolysed collagen (EHC) vs. glucosamine sulphate (GS) in the treatment of knee osteoarthritis (KOA). Int Orthop. 2011;35:341-348.
Google Scholar | Crossref | Medline47. Wangroongsub, Y, Tanavalee, A, Wilairatana, V, Ngarmukos, S. Comparable clinical outcomes between glucosamine sulfate-potassium chloride and glucosamine sulfate sodium chloride in patients with mild and moderate knee osteoarthritis: a randomized, double-blind study. J Med Assoc Thai. 2010;93:805-811.
Google Scholar | Medline48. Bruyere, O, Scholtissen, S, Neuprez, A, Hiligsmann, M, Toukouki, A, Reginster, JY. Impact of chondroitin sulphate on health utility in patients with knee osteoarthritis: towards economic analysis. J Med Econ. 2009;12:356-360.
Google Scholar | Crossref | Medline49. Fardellone, P, Zaim, M, Saurel, AS, Maheu, E. Comparative efficacy and safety study of two chondroitin sulfate preparations from different origin (avian and bovine) in symptomatic osteoarthritis of the knee. Open Rheumatol J. 2013;7:1-12.
Google Scholar